Study reveals key structure in telomerase enzyme, a target for cancer drugs

Over-activation of telomerase in 90 percent of malignant tumors has made the unusual enzyme a prime target for drug development effortsNew findings revealed a molecular “tug of war” that plays…

Be the first to comment

Leave a Reply

Your email address will not be published.